company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71931000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71931000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30948000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30948000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40983000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41006000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,95109000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,136115000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-95132000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12176000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3688000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,848000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7640000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-102772000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-253000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-102519000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-102519000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-102519000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92400000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.11
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92400000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.11
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92772000.0
Nektar Therapeutics,NKTR,,0000906709,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 16:50:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.11
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45314000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45314000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10237000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10237000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35077000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11585000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31455000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12576000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55616000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20539000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2488000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,320000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,391000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1777000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22316000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,264000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22580000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22580000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22580000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,94800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94079000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,159039000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,159039000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25667000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25667000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133372000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40986000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,108065000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12576000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,161627000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28255000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11174000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1545000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,827000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8802000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37057000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,881000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37938000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37938000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37938000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,94800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94079000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 21:43:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,113725000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,113725000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15430000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15430000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98295000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29401000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,76610000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106011000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7716000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8686000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1225000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,436000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7025000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14741000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,617000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15358000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15358000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15358000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,96800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94213000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37925000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37925000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6245000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6245000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31680000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10181000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27724000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37905000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6225000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2826000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,369000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,249000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2208000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8433000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,278000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8711000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8711000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8711000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,96800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94213000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 20:03:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75800000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9185000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9185000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66615000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19220000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48886000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68106000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1491000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5860000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,856000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,187000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4817000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6308000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,339000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6647000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6647000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6647000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51700000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51700000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94065000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42563000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42563000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4889000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4889000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37674000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10207000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25600000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35807000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1867000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2909000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,393000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,163000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2353000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-486000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-517000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-517000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-517000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51700000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51700000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94065000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 16:34:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33237000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33237000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4296000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4296000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28941000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9013000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23286000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32299000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3358000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2951000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,463000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2464000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5822000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,308000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6130000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6130000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6130000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87600000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87600000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93631000.0
Nektar Therapeutics,NKTR,,0000906709,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 16:05:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15782000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15782000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5450000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5450000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10332000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11498000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33302000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44800000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34468000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2525000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,661000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-445000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2309000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36777000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,718000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37495000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37495000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37495000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112942000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71480000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71480000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21891000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21891000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49589000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46760000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,126766000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,173526000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-123937000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10223000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2244000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1044000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9023000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-132960000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1018000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-133978000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-133978000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-133978000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.19
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.19
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112942000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,FY,2011-01-01,2011-12-31,2014-02-27 16:26:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.19
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55698000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55698000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16441000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16441000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39257000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,35262000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,93464000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,128726000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-89469000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7698000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1583000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-599000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6714000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-96183000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,300000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-96483000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-96483000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-96483000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.86
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.86
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114413000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.86
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,101012000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,101012000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26678000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26678000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74334000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46847000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,124919000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12576000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,184342000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-110008000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10186000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1903000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-208000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8491000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-118499000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,564000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-119063000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-119063000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-119063000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.09
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.09
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114413000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.09
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27068000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27068000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5038000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5038000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22030000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12350000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31018000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43368000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21338000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2543000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,622000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-717000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2638000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23976000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,92000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24068000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24068000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24068000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114413000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q3,2011-07-01,2011-09-30,2012-11-09 15:57:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28630000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28630000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11403000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11403000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17227000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22912000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62446000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,85358000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-68131000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5155000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,961000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,118000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4076000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-72207000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,208000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72415000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72415000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72415000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114153000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,111869000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,111869000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27885000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27885000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83984000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44678000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,121625000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12576000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,178879000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-94895000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10469000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1650000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,758000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8061000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-102956000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,750000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-103706000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-103706000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-103706000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.97
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.97
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114153000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.97
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17331000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17331000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8140000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8140000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9191000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11185000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32270000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43455000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34264000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2570000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,529000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2057000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36321000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,60000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36381000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36381000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36381000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114153000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 16:31:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,137101000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,137101000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24634000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24634000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,112467000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43700000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,114955000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12576000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171231000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58764000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10808000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1514000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,937000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8357000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67121000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,721000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67842000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67842000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-67842000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109200000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108677000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11299000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11299000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3263000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3263000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8036000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11727000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30176000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41903000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33867000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2585000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,432000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,134000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2019000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35886000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,148000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36034000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36034000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36034000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,109200000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,109200000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108677000.0
Nektar Therapeutics,NKTR,,0000906709,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 21:31:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21146000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21146000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7290000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7290000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13856000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10864000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46373000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57237000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43381000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10098000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1865000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2385000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9578000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52959000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-33000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52926000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52926000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52926000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114820000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81191000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81191000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30428000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30428000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50763000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41614000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,148675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,191964000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-141201000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33546000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3298000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30248000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-171449000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,406000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-171855000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-171855000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-171855000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.5
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.5
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114820000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,FY,2012-01-01,2012-12-31,2015-02-25 21:03:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.5
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60045000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60045000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23138000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23138000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36907000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30750000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,102302000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,134727000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-97820000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23448000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1865000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,913000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20670000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-118490000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,439000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118929000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118929000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-118929000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.04
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.04
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114915000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.04
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75827000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75827000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28588000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28588000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47239000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42248000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,135604000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179527000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-132288000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25973000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2526000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,468000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22979000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-155267000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1157000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-156424000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-156424000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-156424000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.37
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.37
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114915000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.37
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18412000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18412000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7228000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7228000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11184000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10068000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34016000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44084000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32900000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11184000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,603000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,156000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10425000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43325000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,222000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43547000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43547000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43547000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114600000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114915000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:07:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41633000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41633000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15910000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15910000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25723000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20682000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68286000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90643000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64920000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12264000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1262000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,757000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10245000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-75165000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,217000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75382000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-75382000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-75382000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114300000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114300000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114649000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,84483000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,84483000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26398000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26398000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58085000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44530000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,132606000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,178811000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-120726000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17332000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2545000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-405000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15192000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-135918000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1027000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-136945000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-136945000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-136945000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114300000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.2
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114300000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.2
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114649000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.2
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23684000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23684000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7203000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7203000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16481000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10268000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33201000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43469000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26988000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7931000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,630000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,97000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7204000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34192000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,93000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34285000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34285000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34285000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114300000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114300000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114649000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 15:35:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78130000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78130000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27335000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27335000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50795000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45447000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,131675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,178797000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-128002000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11971000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2444000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-518000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10045000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-138047000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,994000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-139041000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-139041000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-139041000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114200000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.22
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114200000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.22
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114531000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.22
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17949000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17949000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8707000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8707000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9242000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10414000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35085000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1675000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47174000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37932000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4333000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,632000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,660000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3041000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40973000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,124000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41097000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41097000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41097000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114200000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114200000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114531000.0
Nektar Therapeutics,NKTR,,0000906709,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:46:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,148921000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,148921000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38509000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38509000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110412000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40532000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,190010000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,230542000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-120130000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40762000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1124000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39638000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-159768000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2245000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-162013000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-162013000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-162013000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.4
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.4
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115732000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,FY,2013-01-01,2013-12-31,2016-02-29 17:55:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.4
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31146000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31146000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8960000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8960000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22186000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9834000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48248000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58082000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35896000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10230000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-639000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,741000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10128000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46024000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1635000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47659000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47659000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47659000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.41
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115732000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117775000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117775000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29549000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29549000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88226000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30698000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,141762000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,172460000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-84234000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30532000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,639000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,383000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29510000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-113744000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,610000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-114354000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-114354000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-114354000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115812000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.99
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115812000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.99
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118200000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.99
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,138921000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,138921000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36839000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36839000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102082000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41562000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,188135000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,229697000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-127615000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40630000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1226000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2768000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39088000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-166703000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,577000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-167280000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-167280000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-167280000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115812000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.45
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115812000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.45
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118200000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.45
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60909000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60909000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12877000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12877000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48032000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10643000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43914000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54557000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6525000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10203000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,262000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9825000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16350000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,193000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16543000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16543000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16543000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115812000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115812000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118200000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 06:07:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56866000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56866000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16672000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16672000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40194000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20055000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97848000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,117903000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-77709000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20329000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,523000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,121000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19685000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-97394000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,417000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-97811000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-97811000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-97811000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115500000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115500000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115544000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,96424000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,96424000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31190000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31190000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65234000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40987000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,178237000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,219224000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-153990000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41611000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-739000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2662000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39688000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-193678000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,606000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-194284000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-194284000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-194284000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115500000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.69
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115500000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.69
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115544000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.69
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33862000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33862000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5011000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5011000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28851000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9226000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52230000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61456000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32605000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10141000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,209000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9938000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42543000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,205000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42748000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42748000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42748000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115500000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115500000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115544000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 21:11:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,86246000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,86246000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33382000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33382000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52864000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42029000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,159208000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,201237000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-148373000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39401000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-318000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2765000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36954000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-185327000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,494000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-185821000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-185821000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-185821000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.62
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.62
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115309000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.62
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23004000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23004000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11661000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11661000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11343000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10829000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45618000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56447000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45104000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10188000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,314000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,127000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9747000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54851000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,212000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55063000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55063000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55063000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114700000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115309000.0
Nektar Therapeutics,NKTR,,0000906709,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 20:09:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200707000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200707000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28533000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28533000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,172174000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40925000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,147734000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,188659000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16485000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,38757000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,814000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-37943000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54428000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-512000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53916000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53916000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53916000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126873000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,FY,2014-01-01,2014-12-31,2017-03-01 15:03:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19552000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19552000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6298000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6298000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13254000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12248000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38494000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50742000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37488000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9621000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,280000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9341000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46829000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1146000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45683000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45683000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45683000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126873000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132871000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132871000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9220000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9220000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123651000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9130000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34200000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43330000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80321000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9594000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,126000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9468000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70853000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,248000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,70605000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,70605000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,70605000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127504000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132177000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 21:06:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,181155000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,181155000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22235000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22235000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,158920000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28677000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,109240000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137917000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21003000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29136000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,534000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-28602000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7599000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,634000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8233000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8233000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8233000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127504000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132177000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,212301000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,212301000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31195000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31195000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,181106000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38511000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,157488000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,195999000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14893000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39366000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-639000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1275000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38730000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53623000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2269000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55892000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55892000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-55892000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127504000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132177000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,128400000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48284000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48284000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13015000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13015000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35269000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19547000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,75040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,94587000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-59318000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19542000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,408000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19134000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-78452000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,386000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78838000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78838000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-78838000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125500000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125500000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,140339000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,140339000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34852000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34852000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105487000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40024000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,167202000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,207226000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-101739000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39975000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-523000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1411000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39087000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-140826000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2214000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-143040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-143040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-143040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125500000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.18
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125500000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.18
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.18
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28513000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28513000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5108000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5108000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23405000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9619000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36702000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46321000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22916000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9622000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,96000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9526000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32442000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,195000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32637000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32637000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32637000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125500000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125500000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127040000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 21:34:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145688000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145688000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34755000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34755000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110933000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39631000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,182730000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,222361000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-111428000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40494000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-314000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1309000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39499000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-150927000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2224000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-153151000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-153151000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-153151000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123543000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.29
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123543000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.29
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,124900000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.29
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19771000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19771000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7907000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7907000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11864000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9928000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38338000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48266000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36402000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9920000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,312000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9608000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46010000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46201000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46201000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46201000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123543000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123543000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,124900000.0
Nektar Therapeutics,NKTR,,0000906709,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 21:38:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,230784000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,230784000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34102000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34102000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,196682000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43266000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,182787000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,226053000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29371000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,52980000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1680000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51300000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-80671000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,506000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-81177000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-81177000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-81177000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,133100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,133100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132458000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,FY,2015-01-01,2015-12-31,2018-03-01 16:10:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39370000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39370000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8364000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8364000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31006000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13235000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47135000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60370000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29364000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25061000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,325000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24736000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,37000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54137000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54137000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54137000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,133100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.41
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,133100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132458000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59952000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59952000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6760000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6760000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53192000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9544000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43229000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52773000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,419000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9428000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,898000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8530000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8111000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,92000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8203000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8203000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8203000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136700000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136700000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132631000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 21:20:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,191414000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,191414000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25738000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25738000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,165676000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30031000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,135652000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,165683000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27919000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1355000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26564000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26571000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,469000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27040000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27040000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27040000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136700000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136700000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132631000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,210966000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,210966000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32036000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32036000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,178930000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42279000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,174146000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,216425000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37495000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37540000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1635000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35905000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-73400000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-677000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72723000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72723000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72723000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,136700000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,136700000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132631000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22661000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22661000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10534000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10534000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12127000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10184000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45412000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55596000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43469000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9270000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,246000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9024000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-52493000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,164000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52657000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52657000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52657000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131600000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131600000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131643000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 15:33:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,131462000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,131462000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18978000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18978000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,112484000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20487000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,92423000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112910000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-426000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18491000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,457000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18034000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18460000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,377000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18837000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18837000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18837000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131600000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131600000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131643000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,283885000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,283885000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34496000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34496000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,249389000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41865000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,165117000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,206982000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42407000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37706000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,863000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36843000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5564000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-521000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6085000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6085000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6085000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131600000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,131600000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131643000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,108801000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,108801000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8444000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8444000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,100357000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10303000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47011000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57314000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43043000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9221000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,211000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9010000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,34033000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,213000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33820000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33820000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33820000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131359000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135667000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 16:22:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,289737000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,289737000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29070000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29070000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,260667000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41300000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,156407000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,197707000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62960000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,38058000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,713000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-37345000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25615000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-490000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26105000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26105000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26105000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,131359000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135667000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130100000.0
Nektar Therapeutics,NKTR,,0000906709,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,165436000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,165436000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30215000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30215000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135221000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44275000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,203801000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,248076000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-112855000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,42180000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2387000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39793000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-152648000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,876000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-153524000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-153524000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-153524000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139596000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.1
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,139596000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.1
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139600000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,FY,2016-01-01,2016-12-31,2019-03-01 06:05:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.1
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37450000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37450000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6604000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6604000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30846000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12759000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50232000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62991000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32145000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10333000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,722000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9611000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41756000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,443000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42199000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42199000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42199000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139596000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,139596000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139600000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36336000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36336000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7033000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7033000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29303000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10253000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51951000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62204000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32901000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10516000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,332000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10184000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43085000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,139000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43224000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43224000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43224000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137094000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137094000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135100000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 21:44:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,127986000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,127986000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23611000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23611000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104375000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31516000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,153569000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,185085000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-80710000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,31847000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1665000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30182000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-110892000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,433000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-111325000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-111325000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-111325000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137094000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137094000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135100000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,167356000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,167356000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31975000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31975000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135381000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44751000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,200704000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,245455000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-110074000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,56908000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1990000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-54918000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-164992000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,470000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-165462000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-165462000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-165462000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137094000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.23
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137094000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.22
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135100000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.23
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32768000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32768000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7708000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7708000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25060000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11035000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52350000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63385000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38325000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10609000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,458000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10151000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48476000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,127000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48603000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48603000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48603000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,135000000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135000000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,136350000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 21:36:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,91650000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,91650000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16578000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16578000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75072000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21263000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101618000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,122881000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47809000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21331000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1333000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19998000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67807000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,294000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68101000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68101000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-68101000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,135000000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135000000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,136350000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,190972000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,190972000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31702000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31702000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,159270000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44042000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191982000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,236024000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-76754000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55820000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2556000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-53264000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-130018000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,423000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-130441000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-130441000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-130441000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,135000000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.97
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135000000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.96
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,136350000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.97
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58882000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58882000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8870000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8870000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50012000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10228000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49268000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59496000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9484000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10722000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,875000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9847000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19331000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,167000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19498000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19498000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19498000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139300000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,139300000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135793000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 20:19:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,180865000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,180865000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34528000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34528000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146337000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43191000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,185044000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,228235000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81898000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54481000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2344000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-52137000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-134035000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,460000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-134495000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-134495000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-134495000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139300000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.01
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,139300000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,135793000.0
Nektar Therapeutics,NKTR,,0000906709,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.01
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,307711000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,307711000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30547000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30547000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,277164000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52364000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,268461000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15981000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,336806000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-59642000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40954000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4520000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36434000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-96076000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,616000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-96692000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-96692000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-96692000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155953000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155953000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156000000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,FY,2017-01-01,2017-12-31,2020-02-27 21:29:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,95466000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,95466000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9753000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9753000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85713000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12337000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,81429000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15981000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,109747000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24034000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10967000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1357000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9610000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33644000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,182000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33826000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33826000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33826000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155953000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155953000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156000000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,152928000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,152928000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5674000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5674000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,147254000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12055000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,65714000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77769000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,69485000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10011000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1599000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8412000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61073000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,202000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60871000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60871000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60871000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,156411000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,162641000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 21:22:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,212245000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,212245000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20794000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20794000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,191451000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40027000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187032000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,227059000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35608000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29987000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3163000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26824000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62432000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,434000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62866000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62866000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62866000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,156411000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,162641000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,249695000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,249695000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27398000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27398000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,222297000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52786000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,237264000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,290050000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67753000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40320000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3885000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36435000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-104188000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,877000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-105065000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-105065000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-105065000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,156411000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,162641000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34589000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34589000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8989000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8989000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25600000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15996000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60260000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76256000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50656000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10022000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,906000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9116000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59772000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,99000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59871000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59871000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59871000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155352000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155352000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153500000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 21:56:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59317000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59317000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15120000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15120000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44197000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27972000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,121318000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,149290000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-105093000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19976000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1564000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18412000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-123505000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,232000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-123737000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-123737000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-123737000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155352000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.81
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155352000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.81
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153500000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.81
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,133103000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,133103000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28757000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28757000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104346000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50984000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,223501000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,274485000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-170139000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40825000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2618000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38207000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-208346000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,814000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-209160000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-209160000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-209160000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,155352000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.41
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,155352000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.41
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153500000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.41
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24728000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24728000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6131000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6131000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18597000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11976000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,61058000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73034000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-54437000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9954000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,658000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9296000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-63733000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,133000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63866000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63866000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63866000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,152100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,152100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153666000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:25:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,131282000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,131282000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27476000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27476000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103806000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46023000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,215591000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,261614000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-157808000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41412000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2170000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39242000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-197050000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,842000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-197892000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-197892000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-197892000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,152100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.38
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,152100000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.38
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,153666000.0
Nektar Therapeutics,NKTR,,0000906709,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.38
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1193323000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1193323000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24412000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24412000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1168911000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81443000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,399536000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,480979000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,687932000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,42778000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,37571000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5207000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,682725000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1412000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,681313000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,681313000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,681313000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,169600000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.02
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,180119000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.78
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,169500000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,FY,2018-01-01,2018-12-31,2020-02-27 21:29:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.02
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39826000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39826000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7461000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7461000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32365000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23777000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,108883000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,132660000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-100295000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11803000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12048000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,245000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-100050000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1838000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98212000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98212000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-98212000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,169600000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,180119000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,169500000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27762000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27762000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4783000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4783000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22979000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18718000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,102895000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,121613000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-98634000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10256000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11847000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1591000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-97043000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-900000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-96143000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-96143000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-96143000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,172698000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,172698000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,171700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 19:43:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1153497000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1153497000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16951000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16951000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1136546000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57666000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,290653000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,348319000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,788227000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30975000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25523000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5452000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,782775000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3250000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,779525000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,779525000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,779525000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,172698000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.51
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,172698000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.17
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,171700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.51
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1248963000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1248963000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,26704000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,26704000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1222259000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70003000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,372082000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15981000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,458066000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,764193000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41942000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26880000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15062000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,749131000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3432000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,745699000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,745699000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,745699000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,172698000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.31
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,172698000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.99
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,171700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.31
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1087717000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1087717000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5522000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5522000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1082195000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20261000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88334000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,108595000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,973600000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10360000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12105000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1745000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,975345000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3885000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,971460000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,971460000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,971460000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,171378000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.67
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,182291000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.33
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,171300000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 20:26:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.67
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1125735000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1125735000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12168000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12168000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1113567000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,38948000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187758000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,226706000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,886861000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20719000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13676000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7043000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,879818000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4150000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,875668000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,875668000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,875668000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,171378000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.07
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,182291000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.73
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,171300000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.07
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1374129000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1374129000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27595000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27595000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1346534000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63340000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,334901000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15981000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,414222000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,932312000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41697000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16632000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25065000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,907247000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4534000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,902713000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,902713000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,902713000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,171378000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.26
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,182291000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.92
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,171300000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.26
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38018000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38018000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6646000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6646000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31372000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18687000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,99424000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,118111000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-86739000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10359000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1571000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8788000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-95527000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,265000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-95792000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-95792000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-95792000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,159700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,159700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160884000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 19:42:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,321001000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,321001000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31062000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31062000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,289939000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59075000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,306827000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,15981000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,381883000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-91944000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41359000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5433000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35926000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-127870000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,748000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-128618000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-128618000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-128618000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,159700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,159700000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160884000.0
Nektar Therapeutics,NKTR,,0000906709,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33862000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33862000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5989000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5989000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27873000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27142000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,110369000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137511000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-109638000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12619000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10371000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2248000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-111886000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,432000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-112318000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-112318000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-112318000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174993000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174993000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.64
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174900000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114617000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114617000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21374000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21374000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93243000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,98712000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,434566000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,533278000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-440035000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,46354000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,46335000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-440054000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,613000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-440667000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-440667000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-440667000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174993000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.52
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174993000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.52
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174900000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,FY,2019-01-01,2019-12-31,2020-02-27 21:29:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.52
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,80755000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,80755000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15385000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15385000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65370000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71570000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,324197000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,395767000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-330397000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33735000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35964000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2229000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-328168000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,181000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-328349000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-328349000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-328349000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,175402000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.88
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,175402000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.88
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,176400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.88
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,120581000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,120581000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22846000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22846000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,97735000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,95347000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,433080000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,528427000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-430692000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45538000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,48012000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2474000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-428218000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1657000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-426561000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-426561000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-426561000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,175402000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.37
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,175402000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,176400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.37
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29218000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29218000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4927000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4927000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24291000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23983000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,99048000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,123031000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-98740000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11238000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11492000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,254000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-98486000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,322000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98808000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98808000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-98808000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,175402000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,175402000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,176400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 19:43:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51537000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51537000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10458000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10458000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41079000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47587000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,225149000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,272736000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-231657000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22497000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24472000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1975000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-229682000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-141000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-229541000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-229541000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-229541000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174549000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.32
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174549000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.32
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174500000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.32
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,119125000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,119125000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,22702000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,22702000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,96423000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,90082000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,436927000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,527009000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-430586000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,44556000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,48367000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3811000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-426775000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2879000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-423896000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-423896000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-423896000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174549000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.37
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174549000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174500000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.37
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23315000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23315000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5018000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5018000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18297000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22581000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,106686000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,129267000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-110970000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11206000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11989000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,783000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-110187000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-278000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-109909000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-109909000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-109909000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174549000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174549000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174500000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 20:26:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28222000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28222000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5440000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5440000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22782000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,25006000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,118463000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,143469000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-120687000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11291000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12483000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1192000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-119495000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,137000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-119632000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-119632000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-119632000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,173400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,173400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,173859000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:26:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1183527000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1183527000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23206000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23206000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1160321000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,87762000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,418575000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,506337000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,653984000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43710000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,48483000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4773000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,658757000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1284000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,657473000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,657473000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,657473000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,173400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.93
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,173400000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.69
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,173859000.0
Nektar Therapeutics,NKTR,,0000906709,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.93
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,136968000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,136968000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19745000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19745000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,117223000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,99923000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,425090000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,45189000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,570202000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-452979000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48235000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42204000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6031000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-459010000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,676000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-459686000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-459686000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-459686000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,177800000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.61
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,177800000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.61
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,177185000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.61
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50573000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50573000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3811000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3811000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46762000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26217000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,108987000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,45189000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,180393000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-133631000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13172000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8352000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4820000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-138451000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,200000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-138651000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-138651000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-138651000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,177800000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,177800000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,177185000.0
Nektar Therapeutics,NKTR,,0000906709,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:26:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
